Concepedia

Ellis F. Unger

EF

Statistics

Publications

34

Citations

5.7K

H-Index

27

Active since

1990

Affiliations

National Heart Lung and Blood Institute(Current)

Center for Drug Evaluation and Research

National Institutes of Health

United States Food and Drug Administration

University of California, San Francisco

Ellis F. Unger is an author at National Heart Lung and Blood Institute specializing in medicine, cardiology, and angiogenesis.

Publications per year

1990–2025

34

Publications

34

A call for transparent reporting to optimize the predictive value of preclinical research

Story C. Landis, Susan Amara, Khusru Asadullah et al. · Nature · 2012 · 1.2K citations · Full text

, , +16

Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs.

Shmuel Banai, Michael T. Jaklitsch, Magang Shou et al. · Circulation · 1994 · 602 citations

, , +11

Comparative Effects of Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor on Coronary Collateral Development and the Arterial Response to Injury

Daisy F. Lazarous, Matie Shou, Mickey Scheinowitz et al. · Circulation · 1996 · 387 citations

, , +14

Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular Drugs

Pamela E. Scott, Ellis F. Unger, Marjorie Jenkins et al. · Journal of the American College of Cardiology · 2018 · 361 citations · Full text

, , +15

Dabigatran and Postmarketing Reports of Bleeding

Mary Southworth, Marsha E. Reichman, Ellis F. Unger · New England Journal of Medicine · 2013 · 352 citations

, , +17

1–5 of 34